Corcept Therapeutics Incorporated

CORT · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$127,665$135,551$66,329$77,617
Short-Term Investments$255,669$232,670$365,343$145,918
Receivables$58,076$56,823$46,857$29,025
Inventory$12,412$7,730$6,100$4,988
Other Curr. Assets$8,288$25,862$14,624$8,915
Total Curr. Assets$471,602$458,636$499,253$266,463
Property Plant & Equip (Net)$8,013$315$1,776$1,516
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$219,831$57,176$4,947$112,277
Tax Assets$130,914$90,605$61,465$27,455
Other NC Assets$10,193$14,785$15,989$16,045
Total NC Assets$368,951$162,881$84,177$157,293
Other Assets$0$0$0$0
Total Assets$840,553$621,517$583,430$423,756
Liabilities
Payables$15,376$17,396$11,976$6,908
Short-Term Debt$829$151$1,143$526
Tax Payable$191$2,892$89$513
Deferred Revenue$0$0$0$0
Other Curr. Liab.$82,646$59,687$43,772$26,255
Total Curr. Liab.$140,773$104,505$72,491$47,541
LT Debt$0$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$14,084$10,307$9,097$409
Total NC Liab.$20,191$10,307$9,097$409
Other Liabilities$0$0$0$0
Cap. Leases$6,936$151$1,143$526
Total Liabilities$160,964$114,812$81,588$47,950
Equity
Pref Stock$0$0$0$0
Common Stock$136$133$131$127
Retained Earnings$543,735$402,526$296,386$194,968
AOCI-$217$609-$869-$227
Other Equity$0$0$0$0
Total Equity$679,589$506,705$501,842$375,806
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$840,553$621,517$583,430$423,756
Net Debt-$126,836-$135,400-$65,186-$77,091